Physician profile
Rose M Wright
NPI 1659476877
$1,410.17
in general payments reported to CMS, 2019-2025
14 companies · $647 in 2025
The $647 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.60 · 2022: $42.29 · 2023: $302 · 2024: $373 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,322.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $353.42 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Pfizer INC. | $264.60 | 2022-2025 | |
| Abbvie INC. | $249.27 | 2023-2025 | |
| Glaxosmithkline, LLC. | $132.29 | 2023-2025 | Trelegy Ellipta, Arexvy |
| Otsuka America Pharmaceutical, INC. | $73.51 | 2023-2025 | Rexulti, Nuedexta |
| Exact Sciences Corporation | $73.16 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $50.08 | 2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $47.73 | 2024-2025 | Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $38.12 | 2024 | Camzyos, Eliquis |
| Lundbeck LLC | $34.65 | 2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.67 | 2021 | |
| Dentsply Ih Ab | $25.90 | 2023 | Lofric |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.84 | 2024 | Xifaxan |
| Janssen Pharmaceuticals, INC | $17.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rose Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.